Product NDC: | 42023-122 |
Proprietary Name: | Adrenalin |
Non Proprietary Name: | epinephrine |
Active Ingredient(s): | 1 mg/mL & nbsp; epinephrine |
Administration Route(s): | INTRACARDIAC; INTRAMUSCULAR; INTRASPINAL; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-122 |
Labeler Name: | JHP Pharmaceuticals LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20071001 |
Package NDC: | 42023-122-25 |
Package Description: | 25 VIAL in 1 CARTON (42023-122-25) > 1 mL in 1 VIAL |
NDC Code | 42023-122-25 |
Proprietary Name | Adrenalin |
Package Description | 25 VIAL in 1 CARTON (42023-122-25) > 1 mL in 1 VIAL |
Product NDC | 42023-122 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | epinephrine |
Dosage Form Name | INJECTION |
Route Name | INTRACARDIAC; INTRAMUSCULAR; INTRASPINAL; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20071001 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | JHP Pharmaceuticals LLC |
Substance Name | EPINEPHRINE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |